IL126701A - Inhaler system for inhalation of a dry powder drug - Google Patents
Inhaler system for inhalation of a dry powder drugInfo
- Publication number
- IL126701A IL126701A IL12670197A IL12670197A IL126701A IL 126701 A IL126701 A IL 126701A IL 12670197 A IL12670197 A IL 12670197A IL 12670197 A IL12670197 A IL 12670197A IL 126701 A IL126701 A IL 126701A
- Authority
- IL
- Israel
- Prior art keywords
- inhaler
- drug
- microns
- dry powder
- inhalation
- Prior art date
Links
- 239000003814 drug Substances 0.000 title claims abstract description 31
- 229940079593 drug Drugs 0.000 title claims abstract description 30
- 239000000843 powder Substances 0.000 title claims abstract description 25
- 239000002245 particle Substances 0.000 claims abstract description 30
- 239000000203 mixture Substances 0.000 claims abstract description 14
- 238000012384 transportation and delivery Methods 0.000 claims abstract description 9
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 4
- 102000004169 proteins and genes Human genes 0.000 claims description 4
- 108090000623 proteins and genes Proteins 0.000 claims description 4
- 230000009885 systemic effect Effects 0.000 claims description 4
- 239000000443 aerosol Substances 0.000 claims description 3
- 208000006673 asthma Diseases 0.000 claims description 3
- 229940088597 hormone Drugs 0.000 claims description 3
- 239000005556 hormone Substances 0.000 claims description 3
- 229920001184 polypeptide Polymers 0.000 claims description 3
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 3
- 230000000699 topical effect Effects 0.000 claims description 3
- 230000008021 deposition Effects 0.000 description 14
- 210000004072 lung Anatomy 0.000 description 11
- 125000003003 spiro group Chemical group 0.000 description 8
- 229940071648 metered dose inhaler Drugs 0.000 description 5
- 230000002093 peripheral effect Effects 0.000 description 5
- 229940112141 dry powder inhaler Drugs 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- 238000001727 in vivo Methods 0.000 description 4
- 102000055006 Calcitonin Human genes 0.000 description 3
- 108060001064 Calcitonin Proteins 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- 229960004015 calcitonin Drugs 0.000 description 3
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 description 3
- 230000003434 inspiratory effect Effects 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 229940092705 beclomethasone Drugs 0.000 description 2
- NBMKJKDGKREAPL-DVTGEIKXSA-N beclomethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O NBMKJKDGKREAPL-DVTGEIKXSA-N 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- NDAUXUAQIAJITI-UHFFFAOYSA-N albuterol Chemical group CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1 NDAUXUAQIAJITI-UHFFFAOYSA-N 0.000 description 1
- 230000036765 blood level Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 239000013583 drug formulation Substances 0.000 description 1
- 229940023485 nasal product Drugs 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 229960002052 salbutamol Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 238000012385 systemic delivery Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/0045—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/0045—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
- A61M15/0046—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier
- A61M15/0048—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier the dosages being arranged in a plane, e.g. on diskettes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/06—Solids
- A61M2202/064—Powder
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Otolaryngology (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Flow Control (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1642896P | 1996-04-29 | 1996-04-29 | |
| PCT/US1997/006621 WO1997040819A1 (en) | 1996-04-29 | 1997-04-21 | Methods of dry powder inhalation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL126701A0 IL126701A0 (en) | 1999-08-17 |
| IL126701A true IL126701A (en) | 2001-08-08 |
Family
ID=21777075
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL12670197A IL126701A (en) | 1996-04-29 | 1997-04-21 | Inhaler system for inhalation of a dry powder drug |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US6116237A (cs) |
| EP (1) | EP0896525B1 (cs) |
| JP (2) | JP2000510109A (cs) |
| AT (1) | ATE247948T1 (cs) |
| AU (1) | AU724503B2 (cs) |
| BR (1) | BR9709748A (cs) |
| CA (1) | CA2252814A1 (cs) |
| CZ (1) | CZ343798A3 (cs) |
| DE (1) | DE69724420T2 (cs) |
| DK (1) | DK0896525T3 (cs) |
| ES (1) | ES2205210T3 (cs) |
| HU (1) | HUP9901575A3 (cs) |
| IL (1) | IL126701A (cs) |
| NO (1) | NO984999D0 (cs) |
| NZ (1) | NZ332669A (cs) |
| WO (1) | WO1997040819A1 (cs) |
Families Citing this family (110)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6060069A (en) * | 1991-05-20 | 2000-05-09 | Dura Pharmaceuticals, Inc. | Pulmonary delivery of pharmaceuticals |
| US6681767B1 (en) * | 1991-07-02 | 2004-01-27 | Nektar Therapeutics | Method and device for delivering aerosolized medicaments |
| DE69230613T2 (de) * | 1991-07-02 | 2000-12-28 | Inhale Inc | Verfahren und vorrichtung zum abgeben von medikamenten in aerosolform |
| CZ289029B6 (cs) | 1994-09-21 | 2001-10-17 | Inhale Therapeutic Systems | Způsob aerosolizace práąku, zejména práąkového léku a zařízení k provádění tohoto způsobu |
| CA2252814A1 (en) * | 1996-04-29 | 1997-11-06 | Dura Pharmaceuticals, Inc. | Methods of dry powder inhalation |
| US6309623B1 (en) | 1997-09-29 | 2001-10-30 | Inhale Therapeutic Systems, Inc. | Stabilized preparations for use in metered dose inhalers |
| US6565885B1 (en) | 1997-09-29 | 2003-05-20 | Inhale Therapeutic Systems, Inc. | Methods of spray drying pharmaceutical compositions |
| US20060165606A1 (en) | 1997-09-29 | 2006-07-27 | Nektar Therapeutics | Pulmonary delivery particles comprising water insoluble or crystalline active agents |
| US6433040B1 (en) | 1997-09-29 | 2002-08-13 | Inhale Therapeutic Systems, Inc. | Stabilized bioactive preparations and methods of use |
| US6946117B1 (en) | 1997-09-29 | 2005-09-20 | Nektar Therapeutics | Stabilized preparations for use in nebulizers |
| IL138153A0 (en) | 1998-03-16 | 2001-10-31 | Inhale Therapeutic Syst | Methods and devices for delivering aerosolized active agents |
| US6257233B1 (en) | 1998-06-04 | 2001-07-10 | Inhale Therapeutic Systems | Dry powder dispersing apparatus and methods for their use |
| US7056504B1 (en) | 1998-08-27 | 2006-06-06 | Massachusetts Institute Of Technology | Rationally designed heparinases derived from heparinase I and II |
| UA73924C2 (en) | 1998-10-09 | 2005-10-17 | Nektar Therapeutics | Device for delivering active agent formulation to lungs of human patient |
| JP2000217917A (ja) * | 1999-01-27 | 2000-08-08 | Unisia Jecs Corp | 吸入式投薬器 |
| US6597996B1 (en) | 1999-04-23 | 2003-07-22 | Massachusetts Institute Of Technology | Method for indentifying or characterizing properties of polymeric units |
| US9006175B2 (en) | 1999-06-29 | 2015-04-14 | Mannkind Corporation | Potentiation of glucose elimination |
| US6606992B1 (en) | 1999-06-30 | 2003-08-19 | Nektar Therapeutics | Systems and methods for aerosolizing pharmaceutical formulations |
| US7464706B2 (en) * | 1999-07-23 | 2008-12-16 | Mannkind Corporation | Unit dose cartridge and dry powder inhaler |
| US7305986B1 (en) * | 1999-07-23 | 2007-12-11 | Mannkind Corporation | Unit dose capsules for use in a dry powder inhaler |
| CA2402160C (en) * | 2000-03-08 | 2012-02-14 | Massachusetts Institute Of Technology | Heparinase iii and uses thereof |
| US8404217B2 (en) | 2000-05-10 | 2013-03-26 | Novartis Ag | Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use |
| US7871598B1 (en) | 2000-05-10 | 2011-01-18 | Novartis Ag | Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use |
| AU6124601A (en) | 2000-05-10 | 2001-11-20 | Alliance Pharmaceutical Corporation | Phospholipid-based powders for drug delivery |
| WO2002013897A2 (en) | 2000-08-14 | 2002-02-21 | Advanced Inhalation Research, Inc. | Inhalation device and method |
| AU2001292618A1 (en) | 2000-09-12 | 2002-03-26 | Massachusetts Institute Of Technology | Methods and products related to low molecular weight heparin |
| WO2002032406A2 (en) | 2000-10-18 | 2002-04-25 | Massachusetts Institute Of Technology | Methods and products related to pulmonary delivery of polysaccharides |
| US7225807B2 (en) * | 2001-03-15 | 2007-06-05 | Creare Incorporated | Systems and methods for aerosol delivery of agents |
| US6766799B2 (en) * | 2001-04-16 | 2004-07-27 | Advanced Inhalation Research, Inc. | Inhalation device |
| US7585493B2 (en) | 2001-05-24 | 2009-09-08 | Alexza Pharmaceuticals, Inc. | Thin-film drug delivery article and method of use |
| US7458374B2 (en) | 2002-05-13 | 2008-12-02 | Alexza Pharmaceuticals, Inc. | Method and apparatus for vaporizing a compound |
| US6737042B2 (en) * | 2001-05-24 | 2004-05-18 | Alexza Molecular Delivery Corporation | Delivery of drug esters through an inhalation route |
| US7766013B2 (en) | 2001-06-05 | 2010-08-03 | Alexza Pharmaceuticals, Inc. | Aerosol generating method and device |
| US20070122353A1 (en) | 2001-05-24 | 2007-05-31 | Hale Ron L | Drug condensation aerosols and kits |
| WO2003024514A1 (en) | 2001-09-19 | 2003-03-27 | Advent Pharmaceuticals Pty Ltd | An inhaler |
| DK1458360T3 (da) | 2001-12-19 | 2011-08-29 | Novartis Ag | Pulmonær afgivelse af aminoglycosider |
| GB0201677D0 (en) | 2002-01-25 | 2002-03-13 | Glaxo Group Ltd | Medicament dispenser |
| GB0217199D0 (en) * | 2002-07-25 | 2002-09-04 | Glaxo Group Ltd | Medicament dispenser |
| US6705316B2 (en) | 2002-03-11 | 2004-03-16 | Battelle Pulmonary Therapeutics, Inc. | Pulmonary dosing system and method |
| JP4897198B2 (ja) * | 2002-03-20 | 2012-03-14 | アルカームズ,インコーポレイテッド | 吸入装置で使用する穿孔手段 |
| JP4681231B2 (ja) | 2002-03-20 | 2011-05-11 | マンカインド コーポレイション | 吸入装置 |
| US7185651B2 (en) | 2002-06-18 | 2007-03-06 | Nektar Therapeutics | Flow regulator for aerosol drug delivery and methods |
| GB0217198D0 (en) * | 2002-07-25 | 2002-09-04 | Glaxo Group Ltd | Medicament dispenser |
| JP2005533582A (ja) * | 2002-07-25 | 2005-11-10 | グラクソ グループ リミテッド | 薬剤ディスペンサ |
| GB0217196D0 (en) * | 2002-07-25 | 2002-09-04 | Glaxo Group Ltd | Medicament dispenser |
| EP1534367A1 (en) * | 2002-07-25 | 2005-06-01 | Glaxo Group Limited | Medicament dispenser |
| US7913688B2 (en) * | 2002-11-27 | 2011-03-29 | Alexza Pharmaceuticals, Inc. | Inhalation device for producing a drug aerosol |
| GB0308771D0 (en) * | 2003-04-16 | 2003-05-21 | Univ Loughborough | Pulmonary drug delivery |
| CN100381083C (zh) | 2003-04-29 | 2008-04-16 | 韩力 | 一种非可燃性电子喷雾香烟 |
| ATE520935T1 (de) | 2003-05-21 | 2011-09-15 | Alexza Pharmaceuticals Inc | Verwendung einer schicht aus festem brennstoff, verfahren zum erstellen einer solchen schicht und zugehörige heizvorrichtung |
| GB0313604D0 (en) * | 2003-06-12 | 2003-07-16 | Britannia Pharmaceuticals Ltd | Delivery device for powdered medicament |
| GB0317374D0 (en) * | 2003-07-24 | 2003-08-27 | Glaxo Group Ltd | Medicament dispenser |
| WO2005020963A1 (en) | 2003-09-02 | 2005-03-10 | Ivax Corporation | Process for preparing a medicament |
| GB0327723D0 (en) * | 2003-09-15 | 2003-12-31 | Vectura Ltd | Pharmaceutical compositions |
| JP2007526253A (ja) | 2004-02-19 | 2007-09-13 | コーリー ファーマシューティカル グループ,インコーポレイテッド | 免疫刺激性ウイルスrnaオリゴヌクレオチド |
| WO2006006963A2 (en) * | 2004-04-02 | 2006-01-19 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention | Aerosol delivery systems and methods |
| BRPI0509348A (pt) | 2004-04-21 | 2007-09-11 | Innovata Biomed Ltd | inalador |
| GB0409197D0 (en) | 2004-04-24 | 2004-05-26 | Innovata Biomed Ltd | Device |
| US7540286B2 (en) | 2004-06-03 | 2009-06-02 | Alexza Pharmaceuticals, Inc. | Multiple dose condensation aerosol devices and methods of forming condensation aerosols |
| EP2246086A3 (en) | 2004-08-12 | 2012-11-21 | Alexza Pharmaceuticals, Inc. | Aerosol drug delivery device incorporating percussively activated heating unit |
| GB0418278D0 (en) | 2004-08-16 | 2004-09-15 | Glaxo Group Ltd | Medicament dispenser |
| KR101273120B1 (ko) | 2004-08-20 | 2013-06-13 | 맨카인드 코포레이션 | 다이케토피페라진 합성의 촉매 작용 |
| PL1791542T3 (pl) | 2004-08-23 | 2015-11-30 | Mannkind Corp | Sole diketopiperazyny do dostarczania leków |
| EP1799289B1 (en) * | 2004-09-16 | 2012-05-02 | Giampiero Cossi | Disposable monodose inhaler for powdered medicaments |
| US8337815B2 (en) * | 2004-12-23 | 2012-12-25 | Discovery Laboratories, Inc. | Pulmonary surfactant formulations |
| GB0515584D0 (en) * | 2005-07-28 | 2005-09-07 | Glaxo Group Ltd | Medicament dispenser |
| MX381952B (es) | 2005-09-14 | 2025-03-13 | Mannkind Corp | Metodo para formulacion de farmaco basado en el aumento de la afinidad de agentes activos hacia las superficies de microparticulas cristalinas. |
| JP5473336B2 (ja) | 2006-02-15 | 2014-04-16 | アディウタイド・ファーマスーティカルズ・ゲーエムベーハー | オリゴヌクレオチドの処方に関する組成物および方法 |
| KR20080096809A (ko) | 2006-02-22 | 2008-11-03 | 맨카인드 코포레이션 | 디케토피페라진 및 활성제를 포함하는 마이크로입자의 약학특성의 개선 방법 |
| GB0622827D0 (en) * | 2006-11-15 | 2006-12-27 | Glaxo Group Ltd | Sheet driver for use in a drug dispenser |
| US20080216828A1 (en) | 2007-03-09 | 2008-09-11 | Alexza Pharmaceuticals, Inc. | Heating unit for use in a drug delivery device |
| US8496002B2 (en) * | 2007-06-12 | 2013-07-30 | Civitas Therapeutics, Inc. | Powder inhaler devices |
| BRPI0814248A2 (pt) * | 2007-06-15 | 2015-01-06 | Boehringer Ingelheim Int | Inalador |
| EP2082762A1 (en) | 2008-01-24 | 2009-07-29 | Boehringer Ingelheim International Gmbh | Inhaler |
| PL2254629T3 (pl) * | 2008-03-27 | 2016-06-30 | Mannkind Corp | Układ inhalatora suchego proszku |
| KR101629154B1 (ko) | 2008-06-13 | 2016-06-21 | 맨카인드 코포레이션 | 건조 분말 흡입기 및 약물 투여 시스템 |
| US8485180B2 (en) | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
| CN103751892B (zh) | 2008-06-20 | 2017-03-01 | 曼金德公司 | 用于对吸入工作进行实时描绘的交互式设备和方法 |
| TWI494123B (zh) | 2008-08-11 | 2015-08-01 | Mannkind Corp | 超快起作用胰島素之用途 |
| EP2346556B1 (en) | 2008-09-26 | 2014-11-05 | Oriel Therapeutics, Inc. | Dry powder inhalers with dual piercing members and related devices and methods |
| BRPI0919044B8 (pt) * | 2008-09-26 | 2021-06-22 | Oriel Therapeutics Inc | conjunto de recipientes de dose de pó seco, inalador de pó seco, e, método para fabricar um conjunto de recipientes de dose |
| CA2732827C (en) * | 2008-10-01 | 2016-10-11 | Oriel Therapeutics, Inc. | Dry powder inhalers with rotating piercing mechanisms and related devices and methods |
| US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
| JP5510968B2 (ja) | 2009-02-23 | 2014-06-04 | 日本たばこ産業株式会社 | 非加熱型たばこ香味吸引器 |
| EP2676695A3 (en) * | 2009-03-11 | 2017-03-01 | MannKind Corporation | Apparatus, system and method for measuring resistance of an inhaler |
| KR20190090092A (ko) | 2009-06-12 | 2019-07-31 | 맨카인드 코포레이션 | 한정된 비표면적을 갖는 디케토피페라진 마이크로입자 |
| WO2011039646A2 (en) | 2009-09-30 | 2011-04-07 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Papilloma virus -like particles for targeted gene delivery |
| EP2496295A1 (en) | 2009-11-03 | 2012-09-12 | MannKind Corporation | An apparatus and method for simulating inhalation efforts |
| KR20130117755A (ko) | 2010-06-21 | 2013-10-28 | 맨카인드 코포레이션 | 건조 분말 약물 운반 시스템 및 방법 |
| AU2012236150B2 (en) | 2011-04-01 | 2016-03-31 | Mannkind Corporation | Blister package for pharmaceutical cartridges |
| WO2012174472A1 (en) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | High capacity diketopiperazine microparticles |
| HK1200318A1 (en) | 2011-10-24 | 2015-08-07 | 曼金德公司 | Methods and compositions for treating pain |
| ES2624294T3 (es) | 2012-07-12 | 2017-07-13 | Mannkind Corporation | Sistemas de suministro de fármacos en polvo seco |
| KR101466616B1 (ko) | 2012-10-11 | 2014-11-28 | 한미약품 주식회사 | 건조분말 흡입장치 |
| WO2014066856A1 (en) | 2012-10-26 | 2014-05-01 | Mannkind Corporation | Inhalable influenza vaccine compositions and methods |
| WO2014074797A1 (en) * | 2012-11-09 | 2014-05-15 | Civitas Therapeutics, Inc. | Ultra low density pulmonary powders |
| US8545878B1 (en) | 2012-11-09 | 2013-10-01 | Civitas Therapeutics, Inc. | Capsules containing high doses of levodopa for pulmonary use |
| US10034988B2 (en) * | 2012-11-28 | 2018-07-31 | Fontem Holdings I B.V. | Methods and devices for compound delivery |
| SG10201708090TA (en) | 2013-03-15 | 2017-11-29 | Mannkind Corp | Microcrystalline diketopiperazine compositions and methods |
| JP6491658B2 (ja) | 2013-07-18 | 2019-03-27 | マンカインド コーポレイション | 熱安定性乾燥粉末医薬組成物及び方法 |
| CN105517607A (zh) | 2013-08-05 | 2016-04-20 | 曼金德公司 | 吹入设备和方法 |
| WO2015042412A1 (en) | 2013-09-20 | 2015-03-26 | E-Nicotine Technology. Inc. | Devices and methods for modifying delivery devices |
| WO2015148905A1 (en) | 2014-03-28 | 2015-10-01 | Mannkind Corporation | Use of ultrarapid acting insulin |
| EP3191162B1 (en) | 2014-09-10 | 2022-02-23 | Fontem Holdings 1 B.V. | Methods and devices for modulating air flow in delivery devices |
| US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
| US10806770B2 (en) | 2014-10-31 | 2020-10-20 | Monash University | Powder formulation |
| PL3247235T3 (pl) | 2015-01-22 | 2021-04-06 | Fontem Holdings 1 B.V. | Elektroniczne urządzenia odparowujące |
| IT201600093878A1 (it) | 2016-09-19 | 2018-03-19 | Hollycon Italy Pte Ltd S R L | Inalatore monodose a perdere per medicinali in polvere |
| WO2018071425A1 (en) | 2016-10-11 | 2018-04-19 | Microdose Therapeutx, Inc. | Inhaler and methods of use thereof |
| WO2019152873A1 (en) | 2018-02-02 | 2019-08-08 | Alexza Pharmaceuticals, Inc. | Electrical condensation aerosol device |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB248400A (cs) * | 1925-02-28 | 1926-11-18 | Societe Francaise Des Films Herault | |
| US3831606A (en) * | 1971-02-19 | 1974-08-27 | Alza Corp | Auto inhaler |
| IT1220979B (it) * | 1981-06-04 | 1990-06-21 | Lofarma Farma Lab | Capsule contenenti un allergene e procedimento per la loro preparazione |
| GB8432063D0 (en) * | 1984-12-19 | 1985-01-30 | Riker Laboratories Inc | Physically modified steroids |
| CA2058764A1 (en) * | 1989-04-28 | 1990-10-29 | Peter D. Hodson | Dry powder inhalation device |
| US5176132A (en) * | 1989-05-31 | 1993-01-05 | Fisons Plc | Medicament inhalation device and formulation |
| US5492112A (en) * | 1991-05-20 | 1996-02-20 | Dura Pharmaceuticals, Inc. | Dry powder inhaler |
| US5327883A (en) * | 1991-05-20 | 1994-07-12 | Dura Pharmaceuticals, Inc. | Apparatus for aerosolizing powdered medicine and process and using |
| US5469843A (en) * | 1991-11-12 | 1995-11-28 | Minnesota Mining And Manufacturing Company | Inhalation device |
| AU679700B2 (en) * | 1992-10-19 | 1997-07-10 | Dura Pharmaceuticals, Inc. | Dry powder inhaler |
| SE9203743D0 (sv) * | 1992-12-11 | 1992-12-11 | Astra Ab | Efficient use |
| US5354934A (en) * | 1993-02-04 | 1994-10-11 | Amgen Inc. | Pulmonary administration of erythropoietin |
| US5792057A (en) * | 1993-05-21 | 1998-08-11 | Aradigm Corporation | Ventilation imaging using a fine particle aerosol generator |
| US5388574A (en) * | 1993-07-29 | 1995-02-14 | Ingebrethsen; Bradley J. | Aerosol delivery article |
| JPH0753358A (ja) * | 1993-08-17 | 1995-02-28 | Teijin Ltd | 吸入剤 |
| US5524613A (en) * | 1993-08-25 | 1996-06-11 | Habley Medical Technology Corporation | Controlled multi-pharmaceutical inhaler |
| US5522385A (en) * | 1994-09-27 | 1996-06-04 | Aradigm Corporation | Dynamic particle size control for aerosolized drug delivery |
| US5503869A (en) * | 1994-10-21 | 1996-04-02 | Glaxo Wellcome Inc. | Process for forming medicament carrier for dry powder inhalator |
| US5645051A (en) * | 1995-04-21 | 1997-07-08 | Dura Pharmaceuticals, Inc. | Unit dose dry powder inhaler |
| US5622166A (en) * | 1995-04-24 | 1997-04-22 | Dura Pharmaceuticals, Inc. | Dry powder inhaler delivery system |
| CA2252814A1 (en) * | 1996-04-29 | 1997-11-06 | Dura Pharmaceuticals, Inc. | Methods of dry powder inhalation |
-
1997
- 1997-04-21 CA CA002252814A patent/CA2252814A1/en not_active Abandoned
- 1997-04-21 BR BR9709748-9A patent/BR9709748A/pt not_active IP Right Cessation
- 1997-04-21 AT AT97921298T patent/ATE247948T1/de active
- 1997-04-21 EP EP97921298A patent/EP0896525B1/en not_active Revoked
- 1997-04-21 NZ NZ332669A patent/NZ332669A/xx unknown
- 1997-04-21 ES ES97921298T patent/ES2205210T3/es not_active Expired - Lifetime
- 1997-04-21 HU HU9901575A patent/HUP9901575A3/hu unknown
- 1997-04-21 AU AU27371/97A patent/AU724503B2/en not_active Ceased
- 1997-04-21 DK DK97921298T patent/DK0896525T3/da active
- 1997-04-21 CZ CZ983437A patent/CZ343798A3/cs unknown
- 1997-04-21 WO PCT/US1997/006621 patent/WO1997040819A1/en not_active Ceased
- 1997-04-21 JP JP09538984A patent/JP2000510109A/ja active Pending
- 1997-04-21 IL IL12670197A patent/IL126701A/en not_active IP Right Cessation
- 1997-04-21 DE DE69724420T patent/DE69724420T2/de not_active Expired - Lifetime
- 1997-04-24 US US08/847,287 patent/US6116237A/en not_active Expired - Lifetime
-
1998
- 1998-10-27 NO NO984999A patent/NO984999D0/no not_active Application Discontinuation
-
2009
- 2009-02-24 JP JP2009040744A patent/JP2009148586A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| ATE247948T1 (de) | 2003-09-15 |
| HUP9901575A3 (en) | 1999-11-29 |
| ES2205210T3 (es) | 2004-05-01 |
| WO1997040819A1 (en) | 1997-11-06 |
| BR9709748A (pt) | 2000-01-11 |
| JP2000510109A (ja) | 2000-08-08 |
| JP2009148586A (ja) | 2009-07-09 |
| HUP9901575A2 (hu) | 1999-08-30 |
| AU2737197A (en) | 1997-11-19 |
| AU724503B2 (en) | 2000-09-21 |
| DK0896525T3 (da) | 2003-12-01 |
| NO984999L (no) | 1998-10-27 |
| NZ332669A (en) | 1999-02-25 |
| IL126701A0 (en) | 1999-08-17 |
| EP0896525A4 (en) | 2001-01-10 |
| EP0896525A1 (en) | 1999-02-17 |
| US6116237A (en) | 2000-09-12 |
| EP0896525B1 (en) | 2003-08-27 |
| CZ343798A3 (cs) | 1999-02-17 |
| CA2252814A1 (en) | 1997-11-06 |
| DE69724420D1 (de) | 2003-10-02 |
| DE69724420T2 (de) | 2004-06-09 |
| NO984999D0 (no) | 1998-10-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0896525B1 (en) | Methods of dry powder inhalation | |
| US5934273A (en) | System for dispensing pharmaceutically active compounds | |
| US6250300B1 (en) | System for dispensing pharmaceutically active compounds | |
| US6881398B2 (en) | Therapeutic dry powder preparation | |
| EP1143931B1 (en) | Pulmonary drug delivery | |
| JP4378057B2 (ja) | 流動抵抗調節されたエアロゾル化活性薬剤送達 | |
| RU2002134467A (ru) | Способ высокоэффективной доставки аэрозоля с большой терапевтической массой | |
| US20020144680A1 (en) | Method and device for releasing powder | |
| AU2001275368A1 (en) | Highly efficient delivery of a large therapeutic mass aerosol | |
| Bisgaard et al. | Spacer devices | |
| Hilman | Aerosol deposition and delivery of therapeutic aerosols | |
| WO2002089884A1 (en) | Aerosol medication delivery system with breath activated means | |
| O′ Callaghan | Targeting drug delivery to the lungs by inhalation | |
| MXPA98008976A (en) | Methods for inhalation of dusts se | |
| WO2005060480A2 (en) | Portable gas operating inhaler | |
| EP1110547A2 (en) | Helium and neon as means delivering drug in inhaler | |
| Hardy | Drug delivery to the respiratory tract | |
| Ganderton | Patients, devices and formulations | |
| Elwood | Extrafine CFC-free beclomethasone aerosol hits the right spot |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| RH1 | Patent not in force |